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1. Introduction
   Leishmaniasis is a parasitic disease that is found in 
parts of the tropics, subtropics, South American, Asia 
and Southern Europe. It has been estimated that there 
are 2 million new cases of leishmaniasis every year in the 
world, of which 1.5 million are categorized as cutaneous 
leishmaniasis and 0.5 million are visceral leishmaniasis[1-3]. 
This disease is caused by infection with Leishmania 
parasites that transmit to human beings through the bite of 
the female Phlebotomine sand flies. The parasites have a 
digenetic life cycle and exist in two distinct morphologies, 
the promastigote in sand fly vectors and the amastigote in 
mammalian hosts[4].
   After the infection inside the mammalian hosts, 
Leishmania  parasites infect the macrophages of 
reticuloendothelial tissue, differentiate into nonmotile 
amastigotes and then proliferate in the phagolysosomal 
vacuoles. In this process, Leishmania parasites in 
promastigote form are engulfed by macrophages but are 
resistant to proteolysis and degradation in the phagosome 
and transformed to amastigotes[5]. The Leishmania must 
endure harsh conditions inside the phagosome like the 
oxidative burst used by the macrophage to destroy foreign 
material inside the phagosome that consists of an attack 
by superoxide and hydroxyl radicals on the parasite. 
Accordingly, nitric oxide (NO) is a potent leishmanicidal 
factor in macrophages produced by the NO synthases, which 
is tightly regulated in response to infection by pathways 
that are not completely elucidated[6,7]. According to the 
study of Lima-Junior et al.[8], the NLRP3 inflammasome 
is activated in response to Leishmania infection and 
is important to restrict the parasite replication both in 
macrophages and in vivo as demonstrated through the 
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infection of inflammasome-deficient mice with Leishmania 
amazonensis, Leishmania braziliensis and Leishmania 
infantum chagasi. Also inflammasome-driven interleukin-
1β (IL-1β) production which facilitates host resistance to 
infection, as signaling through IL-1 receptor and MyD88, 
was necessary and sufficient to trigger inducible nitric oxide 
synthase (NOS2)-mediated production of NO[8]. 
   Therefore, studies show that IL-1β is an important 
interleukin for host resistance to infection, particularly 
intracellular parasites which contributes to induce NOS2-
mediated production of NO as a major host defense 
mechanism against Leishmania spp.[9-12]. On the other hand, 
studies showed that the Nod-like receptor (NLR) family is a 
significant protein complex which acts as a sensor to detect 
microorganism arrival by macrophage[13,14]. 
   Certain NLRs regulate the assembly of NLRP3 inflammasome 
as a multimeric complex that contains active caspase-1, one 
of the key components of this complex with proteolytically 
enzyme activity that cleaves other proteins such as the 
precursor forms of inflammatory cytokines interleukin-1β 
and interleukin 18, into active mature peptide structures. 
Generally caspase-1 is activated when an external agent 
arrives into the macrophage and leads to the induction of 
IL-1β processing and secretion, which is transcriptionally 
regulated by IL-1β secretion when microbial components are 
sensed by pattern recognition receptors[8,15-17]. 
   So, it is noteworthy that the activation of inflammasome 
leads to autonomous macrophage mechanisms that are 
culminated by the restriction of intracellular parasite 
replication. These processes involve the regulation of IFN-γ 
and the processing of IL-1β, which facilitate the expression 
of NOS2 required for NO-mediated restriction of Leishmania 
replication in macrophages[11,12].
   Based on the importance of caspase-1 and IL-1β in 
inflammasome pathway and severity of leishmaniasis disease 
in humans, for the first time in this study, caspase-1 activity 
and IL-18 and IL-1β secretion levels were investigated and 
measured in macrophages infected with Leishmania major 
(L. major).
2. Materials and methods
2.1. Cell culture and infection process
   To investigate the amount of caspase-1 enzyme in 
infected macrophages with L. major, L. major MRO/IR/57/
ER was prepared from the Pasteur Institute in Tehran. 
Then the parasites were cultured into the Novy-MacNeal-
Nicolle biphasic medium and supplemented with 250 IU/mL 
penicillin and 250 µg/mL of streptomycin. After 3 d, a new 
smear was extracted from the biphasic liquid phase and was 
evaluated by using microscope. Promastigotes were counted 
by using hemocytometer slide. After the number of parasites 
reached to 2伊106/mL, promastigote were transferred to RPMI-
1640 medium which containing 10% fetal calf serum at 25 
°C until it reached to 7伊107/mL. After 3 to 4 d, the procyclic 
forms of the parasite which are less infective turned into 
the metacyclic forms which are highly infective. Murine 
macrophage cell lines J774G8 were supplied from the Cell 
Bank of the Pasteur Institute of Iran. Macrophages were 
maintained into a flask which containing RPMI-1640, 15% 
fetal calf serum, 100 mg/mL streptomycin and 100 IU/mL 
penicillin and were incubated at 37 °C with 5% CO2. After 
growth, the macrophages were trypsinated and cultured 
in 6 well plates about 1伊106 cells/well at room temperature 
for 24 h. Promastigotes in the stationary phase which were 
converted to metacyclic used for macrophage infection with 
10 parasites per cell and incubated at 37 °C for 2 h.  
   To remove free promastigotes from the culture medium, the 
supernatant of cell culture was discarded, and macrophages 
were gently washed three times by the RPMI-1640 medium. 
A total of 5 mL of the fresh RPMI-1640 medium were added to 
the previous samples and incubated for 6-18-30 h[18,19]. To 
detect the infected macrophages with intracellular parasites, 
the 400伊 Inverted Tissue Culture Microscope (tv0012000m 
USA) was used. Uninfected macrophages were cultured on 
similar manner.
2.2. Caspase-1 activity assay 
   To assess the activity of DEVD-dependent caspase, the 
CPP32/caspase-1 fluorometric protease assay kit (Biovision 
Company USA) was used. Enzyme activity is measured by 
using the substrate refraction (DEVD-AFC) by the enzyme. 
Crude substrate DEVD-AFC (Asp-Glu-Val-Asp-7-amino-
4-trifluoromethyl coumarine) emits blue light (400 nm), 
while in the present of caspase and its activity, the released 
AFC produces greenish yellow light (505 nm), which called 
fluorometer. The comparison between the infectious sample 
and the uninfected control, showed an increase in enzyme 
activity. 
   For caspase-1 activity assay, the reaction buffer 2伊 was 
divided into 300 µL volumes and then 3 µL of dithiothreitol 
was added to the reactant buffer (final concentration 10 
mmol/L). For cell lysis, lysis buffer was added as much as 
three times of the cell amount, and homogenized. In the next 
stage, 50 µL of the suspension was transferred on ice, after 
10 min, 50 mL of the reactant buffer containing dithiothreitol 
and 5 µL of DEVD-AFC substrate (final concentration of 
50 mmol/L was added to it then was placed at 37 °C for 2 
h. In the end, the fluorescent intensity was read by the 
fluorometer device (JASCO, FP-6200, Japan), in excitation 
wavelength of 400 nm and emission wavelength of 505 nm. 
The increase in enzyme activity was measured by comparing 
the results of infectious and control sample in different time.
2.3. ELISA test to assess the level of IL-1β in the cellculture 
supernatant 
   To evaluate IL-1β, ELISA IL-1β kit (RayBiotech, USA) was 
used. During the first step of incubation, 100 µL cell culture 
supernatant was added to each well and incubated for 1 
d at -4 °C and then were washed and added to specific 
biotinylated monoclonal antibody against IL-1β. Then 
streptavidin-peroiydase enzyme was added and after 
incubation and was washed to remove unbound enzymes, 
suitable amount of enzyme substrate was added to create a 
colored product. The color intensity was directly proportional 
to the concentration of IL-1β in the samples.  
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3. Results 
3.1. Comparison between caspase-1 activity in infected and 
non-infected murine macrophages
   Mean values of caspase-1 activity were compared in 
infected and non-infected murine macrophage cell lines 
J774G8 by 1 mg of total cell culture lysate protein. Results 
showed an increase in caspase-1 activity in infected 
samples compared to non-infected (control) murine 
macrophages. According to these results, the inflammatory 
system of macrophage was stimulated by L. major (P<0.05) 
(Figure 1).
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Figure 1. Caspase-1 activity after 6, 18, 30 h in macrophages after being 
infected by L. major.
3.2. Analysis of IL-1β secretion in in infected murine 
macrophages with L. major by ELISA.  
   The IL-1β secretion level was evaluated by ELISA test. 
Results showed an increase in the production of IL-1β in 
infected samples compared to the control (Figure 2).
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Figure 2. IL-1β secretion in infected macrophages after 6, 18 and 30 h 
measured by ELISA test. 
In this period, an increase in the production of IL-1β can be observed by 
infected macrophages compared with the control. The highest increase in 
IL-1β production was seen after 6 h of infection. 
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4. Discussion 
   To overcome Leishmania, it is necessary to develop an 
appropriate immune response against the parasite. Some 
species of Leishmania are discovered to be immunologically 
dormant or silent which avoid recognition by innate 
immune receptors during the infection[8,11,12,20]. Our study 
revealed that caspase-1 and IL-1β are increased during 
the infection. This finding confirms that the activation of 
inflammasome pathway could be one of the innate immunity 
pathways against L. major. Activation of this pathway 
increases the production of IFN-β and γ which leads to 
the expression of NOS2, an essential enzyme producing NO 
that limits the parasite proliferation in macrophages[21-
24]. There are also reports that measure the activity of beta 
signaling pathway to determine the intensity of disease 
in humans[25,26]. The results of in vivo studies showed 
that the mice with deficiency in caspase-1, IL-1β and IL-
18 had a greater sensitivity to these parasites; therefore 
the activation of this pathway is necessary to inhibit the 
parasite proliferation. Regarding the overproduction of 
these products in infected samples compared to control, 
the important role of caspase-1 to resist against parasites is 
confirmed. Detecting the main pathways in host resistance 
to Leishmania is used as new therapeutic strategies through 
modifying inflammasome pathway to treat chronic diseases 
such as Leishmania[27,28]. Studies showed that Shigella 
needs caspase-1 and of IL-β and 18 productions to be 
virulent, mice deficient in production of capsase-1 are 
unable to develop inflammation[21,29]. Also, it was found that 
the activation of monocytogenes caspase-1 stimulates the 
production of IL-1β and IL-18[22,30]. Lara-Tejero et al. in 
2006 examined the role of caspase-1 in the pathogenicity of 
Salmonella typhimurium in macrophages and measured the 
expression levels of IPAF, ASC, NALP3 genes at the level of 
mRNA in macrophages. In murine macrophages lacking ASC 
and NALP3, caspase-1 is activated, these results suggests 
that Salmonella can activate caspase-1 independent of 
ASC and NALP3, however it is not activated in macrophages 
lacking IPAF caspase. The significance of IPAF in activating 
caspase-1 was established[31].
   Miao et al. showed that Pseudomonas aeruginosa activates 
caspase-1 in macrophages and causes the secretion of IL-
1β and is 18[17]. They also proved that the T3ss flagellin 
antigen of the bacteria activates inflammasome pathway 
dependent IPAF and this path has been followed by 
activation of caspase-1 enzymes. The role of NAIP5 in the 
activation of caspase-1 was examined in this study, the 
caspase-1 is activated in macrophages lacking NAIP5[25]. 
Ozoren et al. in 2006 examined the distinct roles of TLR2 and 
ASC adapter molecules in IL-1β secretion in response to 
Listeria monocytogenes[30]. According to this study, the role 
of ASC in the host defense against the intracellular pathogen 
Listeria monocytogene is essential to secrete IL-1β and 18. 
However it is not necessary to produce IL-6, TNF-α, IFN-β 
in macrophages infected with Listeria. In macrophages 
deficient in ASC, caspase-1 activation does not occur, but 
activation of NF-κB, P38 is not affected[30]. 
   The results imply the effect of L. major on the increased 
expression of inflammatory pathway-activating proteins 
and increased production of caspase-1 and IL-1β. Further 
research is recommended using other methods in terms of 
in vivo on mouse; the results can be generalized to humans 
after the experimental stage. Further in vitro studies and 
clinical trials are needed to confirm this hypothesis. Gaining 
much more information on the mechanisms of the activation 
of inflammatory pathways and the regulation of pathways 
will enhance the understanding about the pathology of some 
chronic inflammatory diseases as well as new therapeutic 
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goals[32,33].
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